Closing the Loop with Gates: A Scale-up-Gated Design–Build–Test–Learn Framework for Industrial Fermentation
Microorganisms · 19.08.2026 · 14 (8) · 1830
DOI: 10.3390/microorganisms14081830 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 19.08.2026. Verfasst von Xiang He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Research and Utilization of Resource Plants on the Loess Plateau, Engineering Research Center of Microbial Resources Develo…. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University Student Innovation and Entrepreneurship Training Program of China, Shaanxi Provincial Natural Science Basic Research Program, Scientific Research Funding Program of the Department of Education of Shaanxi Province.
Abstract (Originalsprache)
The global fermentation industry faces persistent bottlenecks in scaling laboratory innovations to industrial production, and the integration of synthetic biology (SynBio) and artificial intelligence (AI) within the Design–Build–Test–Learn (DBTL) loop has yielded inconsistent industrial outcomes. This review proposes that transformative impact requires a “scale-up-gated DBTL” framework, in which explicit decision gates constrain every iteration. At the Design phase, scale-down simulation data must inform genetic design choices. At the Test phase, downstream processing compatibility and industrial robustness metrics are enforced as non-negotiable evaluation criteria. At the Learn phase, techno-economic analysis (TEA) and life-cycle assessment (LCA) serve as the convergence criteria, replacing traditional titer plateaus. Through a qualitative cross-sectoral analysis of food, pharmaceutical, agricultural, and energy fermentation, the analysis reveals that workflows incorporating such constraints consistently bridge the valley of death, whereas unconstrained DBTL systematically converges on laboratory optima that are industrially unviable. Five strategic priorities are outlined—embedding TEA/LCA into DBTL, adopting scale-down simulation, building open fermentation data repositories, harmonizing regulatory frameworks, and fostering cross-disciplinary training—as prerequisites for progressing toward fully autonomous, scale-up-aware biomanufacturing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaanxi Key Laboratory of Research and Utilization of Resource Plants on the Loess Plateau, Engineering Research Center of Microbial Resources Development and Green Recycling of the University of Shaanxi Province, Colle…
- Center of Edible Fungi, Northwest A&F University, Yangling, Xianyang 712100, China.
ORCID-Profile: Jianzhao Qi, Pengfei Jin
Förderung
- National University Student Innovation and Entrepreneurship Training Program of China
- Shaanxi Provincial Natural Science Basic Research Program
- Scientific Research Funding Program of the Department of Education of Shaanxi Province
- PhD Student Research Startup Fund of Yan'an University
- PhD Student Research Startup Fund of Yan’an University
Zitieren
APA
He, X., Hu, Y., Zhu, Y., Li, X., Wang, K., Dong, L., He, X., Liu, Y., Qi, J., & Jin, P. (2026). Closing the Loop with Gates: A Scale-up-Gated Design–Build–Test–Learn Framework for Industrial Fermentation. Microorganisms, 14(8), 1830. https://doi.org/10.3390/microorganisms14081830
Vancouver
He X, Hu Y, Zhu Y, Li X, Wang K, Dong L, et al. Closing the Loop with Gates: A Scale-up-Gated Design–Build–Test–Learn Framework for Industrial Fermentation. Microorganisms. 2026;14(8):1830. doi:10.3390/microorganisms14081830
BibTeX
@article{He2026,
author = {He, Xiang and Hu, Yanling and Zhu, Yao and Li, Xinli and Wang, Kenan and Dong, Liqing and He, Xiaolong and Liu, Yueqin and Qi, Jianzhao and Jin, Pengfei},
title = {Closing the Loop with Gates: A Scale-up-Gated Design–Build–Test–Learn Framework for Industrial Fermentation},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {8},
pages = {1830},
doi = {10.3390/microorganisms14081830}
}
EUVIMED